Clinical and virologic outcomes after changes in first antiretroviral regimen at 7 sites in the Caribbean, Central and South America network

Fundación Arriarán/Facultad de Medicina, Universidad de Chile, Santiago, Chile
Vanderbilt University, Nashville, TN, U.S.A.
Fundación Arriarán/Facultad de Medicina, Universidad de Chile, Santiago, Chile
Vanderbilt University, Nashville, TN, U.S.A.
Fundación Huésped, Buenos Aires, Argentina
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
Le Groupe Haïtien d’Etude du Sarcome de Kaposi et des Infections Opportunistes, Port-au-Prince, Haiti
Instituto Hondureño de Seguridad Social and Hospital Escuela, Tegucigalpa, Honduras
Instituto Nacional de Ciencias Médicas y Nutrición, Mexico City, México
Instituto de Medicina Tropical Alexander von Humboldt, Lima, Peru
Vanderbilt University, Nashville, TN, U.S.A.

Abstract

HIV-infected persons in resource-limited settings may experience high rates of antiretroviral therapy (ART) change, particularly because of toxicity or other nonfailure reasons. Few reports address patient outcomes after these modifications.

Keywords

Antiretroviral agents
Treatment failure
Cohort studies
Latin America
Caribbean region

Citation

WOLFF, Marcelo. et al. Clinical and virologic outcomes after changes in first antiretroviral regimen at 7 sites in the Caribbean, Central and South America network (CCASAnet). Journal of Acquired Immune Deficiency Syndromes, v. 71, n. 1, p. 102-110, 2016

DOI

10.1097/QAI.0000000000000817

ISSN

1525-4135

Notes

CCASAnet- Caribbean, Central and South America Network for HIV Epidemiology

Please use this identifier to cite or link to this item: https://www.arca.fiocruz.br/handle/icict/29361

Type

Copyright

Restricted access

Embargo date

2022-01-01

Collections

Share

Statistics

Metadata

Author

Affilliation

Abstract

Keywords

Citation

DOI

ISSN

Notes